Suzuki, H., Yamashiro, D., Ogawa, S., Kobayashi, M., Cho, D., Iizuka, A., Takada, M., Isokawa, M., Nagao, K., & Fujiwara, Y
Combination potential: GLP-1 medications can be combined with SGLT2 inhibitors (another class with kidney benefits) for potentially additive protection
For example, patients with a personal or family history of medullary thyroid carcinoma (MTC) a rare thyroid cancer, or those diagnosed with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should avoid this medication
The primary concern relates to inadvertent pregnancy exposure rather than reduced conception rates
Availability at Enhanced Aesthetics & Wellness Enhanced Aesthetics & Wellness offers a range of weight loss treatments, including alternative medications to Semaglutide